TFC Financial Management’s Supernus Pharmaceuticals SUPN Stock Holding History

TFC Financial Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.37K	Hold	51	–	–	﹤0.01%	555
2026 Q1	$2.64K	Hold	51	–	–	﹤0.01%	512
2025 Q4	$2.54K	Buy	51 +50	+5,000%	+$2.43K	﹤0.01%	513
2025 Q3	$48	Hold	1	–	–	﹤0.01%	962
2025 Q2	$32	Hold	1	–	–	﹤0.01%	961
2025 Q1	$33	Sell	1 -2	-67%	-$71	﹤0.01%	920
2024 Q4	$109	Buy	3 +2	+200%	+$70	﹤0.01%	817
2024 Q3	$32	Buy	+1	New	+$31	﹤0.01%	960

Other funds holding SUPN

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

TFC Financial Management's SUPN Position: Q2 2026 in Review

TFC Financial Management held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 51 shares worth $2.37K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

TFC Financial Management first reported a position in SUPN in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.64K in Q1 2026. 103 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

TFC Financial Management held 51 shares of Supernus Pharmaceuticals worth $2.37K as of Q2 2026.
TFC Financial Management left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
Supernus Pharmaceuticals made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #555 holding.
TFC Financial Management first reported a position in Supernus Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
TFC Financial Management's Supernus Pharmaceuticals position peaked at $2.64K in Q1 2026.
103 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.